Stay updated on AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial

Sign up to get notified when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added; Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:33:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Narcolepsy as a condition and a Genetic and Rare Diseases Information Center resource; updated to Revision v3.4.2. Removed the funding-status notice and the prior revision note (v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T14:28:47.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding/status notice was added at the top of the page and the revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:04.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The new page adds a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:38.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:21:40.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all study sites by state/province (Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Ontario). This expands core content by detailing where the trial sites are located.
    Difference
    2%
    Check dated 2025-12-23T21:00:11.000Z thumbnail image

Stay in the know with updates to AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.